You are here:
Information Letter on Vfend®: possible occurrence of squamous cell carcinomas of the skin
2010.09.27
Active substance: voriconazole
Important safety-relevant information on the potential risk of the occurence of squamous cell carcinomas of the skin in patients taking Vfend® (voriconazole) as long-term treatment.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN